Taking the stress out of melanoma.
A recent study published in Molecular Cell describes a mechanism whereby oncogenic BRAF inhibits AMPK in melanoma cells. This may explain why cancer cells expressing oncogenic BRAF grow under conditions of metabolic stress and may provide new therapeutic opportunities to treat this life-threatening disease.